inThought provides a portfolio of analytical and forecasting products and services to both the financial and pharmaceutical markets.

Ben Weintraub, PhD is the Director of Research and Senior Principal for inThought. Dr. Weintraub's background is in immunology and biochemistry. Leon Henderson, M.D. is a Medical Consultant and Senior Principal for inThought, in addition to working as a clinical geneticist in Internal Medicine and Medical and Clinical Genetics at Cedars Sinai Medical Center. Dr. Henderson is also an Assistant Clinical Professor of Medicine at the University of California, Los Angeles Medical School. Ben Weintraub and Leon Henderson lead the inThought team and have collaborated over the past 8 years to develop inThought’s proprietary forecasting models. Marc Engelsgjerd, M.D., is an inThought Principal that oversees coverage of the oncology sector, including marketed products, drug development, clinical trial design, emerging molecular targets, diagnostics, and cancer genomics/personalized medicine. Michael Zuckerman, M.D. is also a medical consultant for inThought and Principal. Dr. Zuckerman is responsible for expanding the inThought expert network of physicians and key opinion leaders. Claudia Wiatr, M.S. is a Principal for inThought covering pharmaceutical/biological agents with a focus in multiple sclerosis, obesity, and psychiatric and gastrointestional diseases/disorders. Julie Hoggatt, MAcc is a Principal for inThought covering medical devices / biologics and pharmaceuticals for infectious disease and migraine. Kayo Higashimura, D.V.M. is a Senior Analysts at inThought. Dr. Higashimura focuses on hemophilia, systemic lupus, inflammatory bowel disease, multiple sclerosis, and type-2 diabetes. Samantha Crofskey is a Senior Analyst at inThought. Ms. Crofskey focuses on neurology and oncology. Chris Martin, MBA is a Senior Analysts at inThought whose focus is hemophilia and worldwide revenue forecasting.